Global Recombinant Protein Drugs Market Professional Survey Report 2018

January 2018 | 117 pages | ID: G8ABC9FC967EN
QYResearch

Abstracts

This report studies Recombinant Protein Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Novo Nordisk
• Amgen
• Sanofi
• Eli Lilly
• Merck Serono
• Ortho Biotech
• Roche
• Kyowa Hakko Kirin
• Pharmingen
• Abcam
• GenSci
• SL PHARM
• Dongbao Pharm
• Ankebio
• NCPC
• Heng Rui

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Recombinant DNA
• Recombinant RNA

By Application, the market can be split into

• Pharmaceutical Industry
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Recombinant Protein Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF RECOMBINANT PROTEIN DRUGS

1.1 Definition and Specifications of Recombinant Protein Drugs
  1.1.1 Definition of Recombinant Protein Drugs
  1.1.2 Specifications of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
  1.2.1 Recombinant DNA
  1.2.2 Recombinant RNA
1.3 Applications of Recombinant Protein Drugs
  1.3.1 Pharmaceutical Industry
  1.3.2 Other
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF RECOMBINANT PROTEIN DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Recombinant Protein Drugs
2.3 Manufacturing Process Analysis of Recombinant Protein Drugs
2.4 Industry Chain Structure of Recombinant Protein Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF RECOMBINANT PROTEIN DRUGS

3.1 Capacity and Commercial Production Date of Global Recombinant Protein Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Recombinant Protein Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Recombinant Protein Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Recombinant Protein Drugs Major Manufacturers in 2016

4 GLOBAL RECOMBINANT PROTEIN DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Recombinant Protein Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Recombinant Protein Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Recombinant Protein Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Recombinant Protein Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Recombinant Protein Drugs Sales Price
  4.4.2 2016 Recombinant Protein Drugs Sales Price Analysis (Company Segment)

5 RECOMBINANT PROTEIN DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Recombinant Protein Drugs Market Analysis
  5.1.1 North America Recombinant Protein Drugs Market Overview
  5.1.2 North America 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.1.4 North America 2016 Recombinant Protein Drugs Market Share Analysis
5.2 China Recombinant Protein Drugs Market Analysis
  5.2.1 China Recombinant Protein Drugs Market Overview
  5.2.2 China 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.2.4 China 2016 Recombinant Protein Drugs Market Share Analysis
5.3 Europe Recombinant Protein Drugs Market Analysis
  5.3.1 Europe Recombinant Protein Drugs Market Overview
  5.3.2 Europe 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.3.4 Europe 2016 Recombinant Protein Drugs Market Share Analysis
5.4 Southeast Asia Recombinant Protein Drugs Market Analysis
  5.4.1 Southeast Asia Recombinant Protein Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Recombinant Protein Drugs Market Share Analysis
5.5 Japan Recombinant Protein Drugs Market Analysis
  5.5.1 Japan Recombinant Protein Drugs Market Overview
  5.5.2 Japan 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.5.4 Japan 2016 Recombinant Protein Drugs Market Share Analysis
5.6 India Recombinant Protein Drugs Market Analysis
  5.6.1 India Recombinant Protein Drugs Market Overview
  5.6.2 India 2012-2017E Recombinant Protein Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Recombinant Protein Drugs Sales Price Analysis
  5.6.4 India 2016 Recombinant Protein Drugs Market Share Analysis

6 GLOBAL 2012-2017E RECOMBINANT PROTEIN DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Recombinant Protein Drugs Sales by Type
6.2 Different Types of Recombinant Protein Drugs Product Interview Price Analysis
6.3 Different Types of Recombinant Protein Drugs Product Driving Factors Analysis
  6.3.1 Recombinant DNA of Recombinant Protein Drugs Growth Driving Factor Analysis
  6.3.2 Recombinant RNA of Recombinant Protein Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E RECOMBINANT PROTEIN DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Recombinant Protein Drugs Consumption by Application
7.2 Different Application of Recombinant Protein Drugs Product Interview Price Analysis
7.3 Different Application of Recombinant Protein Drugs Product Driving Factors Analysis
  7.3.1 Pharmaceutical Industry of Recombinant Protein Drugs Growth Driving Factor Analysis
  7.3.2 Other of Recombinant Protein Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF RECOMBINANT PROTEIN DRUGS

8.1 Novo Nordisk
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Novo Nordisk 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Novo Nordisk 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.2 Amgen
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Amgen 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Amgen 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.3 Sanofi
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Sanofi 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Sanofi 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.4 Eli Lilly
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Eli Lilly 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Eli Lilly 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.5 Merck Serono
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Merck Serono 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Merck Serono 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.6 Ortho Biotech
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Ortho Biotech 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Ortho Biotech 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.7 Roche
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Roche 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Roche 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.8 Kyowa Hakko Kirin
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Kyowa Hakko Kirin 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Kyowa Hakko Kirin 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.9 Pharmingen
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Pharmingen 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Pharmingen 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.10 Abcam
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Abcam 2016 Recombinant Protein Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Abcam 2016 Recombinant Protein Drugs Business Region Distribution Analysis
8.11 GenSci
8.12 SL PHARM
8.13 Dongbao Pharm
8.14 Ankebio
8.15 NCPC
8.16 Heng Rui

9 DEVELOPMENT TREND OF ANALYSIS OF RECOMBINANT PROTEIN DRUGS MARKET

9.1 Global Recombinant Protein Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Recombinant Protein Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Recombinant Protein Drugs Sales Price Forecast
9.2 Recombinant Protein Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Recombinant Protein Drugs Consumption Forecast
  9.2.2 China 2017-2022 Recombinant Protein Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Recombinant Protein Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Recombinant Protein Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Recombinant Protein Drugs Consumption Forecast
  9.2.6 India 2017-2022 Recombinant Protein Drugs Consumption Forecast
9.3 Recombinant Protein Drugs Market Trend (Product Type)
9.4 Recombinant Protein Drugs Market Trend (Application)

10 RECOMBINANT PROTEIN DRUGS MARKETING TYPE ANALYSIS

10.1 Recombinant Protein Drugs Regional Marketing Type Analysis
10.2 Recombinant Protein Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Recombinant Protein Drugs by Region
10.4 Recombinant Protein Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF RECOMBINANT PROTEIN DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL RECOMBINANT PROTEIN DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Protein Drugs
Table Product Specifications of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure Global Production Market Share of Recombinant Protein Drugs by Type in 2016
Figure Recombinant DNA Picture
Table Major Manufacturers of Recombinant DNA
Figure Recombinant RNA Picture
Table Major Manufacturers of Recombinant RNA
Table Applications of Recombinant Protein Drugs
Figure Global Consumption Volume Market Share of Recombinant Protein Drugs by Application in 2016
Figure Pharmaceutical Industry Examples
Table Major Consumers in Pharmaceutical Industry
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Recombinant Protein Drugs by Regions
Figure North America Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Figure China Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Figure Europe Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Figure Japan Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Figure India Recombinant Protein Drugs Market Size (Million USD) (2012-2022)
Table Recombinant Protein Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Recombinant Protein Drugs in 2016
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Industry Chain Structure of Recombinant Protein Drugs
Table Capacity and Commercial Production Date of Global Recombinant Protein Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Recombinant Protein Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Recombinant Protein Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Recombinant Protein Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Recombinant Protein Drugs 2012-2017
Figure Global 2012-2017E Recombinant Protein Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Recombinant Protein Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Recombinant Protein Drugs Capacity and Growth Rate
Table 2016 Global Recombinant Protein Drugs Capacity (K Doses) List (Company Segment)
Table 2012-2017E Global Recombinant Protein Drugs Sales (K Doses) and Growth Rate
Table 2016 Global Recombinant Protein Drugs Sales (K Doses) List (Company Segment)
Table 2012-2017E Global Recombinant Protein Drugs Sales Price (USD/Dose)
Table 2016 Global Recombinant Protein Drugs Sales Price (USD/Dose) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure North America 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure North America 2016 Recombinant Protein Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure China 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure China 2016 Recombinant Protein Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure Europe 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure Europe 2016 Recombinant Protein Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure Southeast Asia 2016 Recombinant Protein Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure Japan 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure Japan 2016 Recombinant Protein Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Doses) of Recombinant Protein Drugs 2012-2017E
Figure India 2012-2017E Recombinant Protein Drugs Sales Price (USD/Dose)
Figure India 2016 Recombinant Protein Drugs Sales Market Share
Table Global 2012-2017E Recombinant Protein Drugs Sales (K Doses) by Type
Table Different Types Recombinant Protein Drugs Product Interview Price
Table Global 2012-2017E Recombinant Protein Drugs Sales (K Doses) by Application
Table Different Application Recombinant Protein Drugs Product Interview Price
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Novo Nordisk Recombinant Protein Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Amgen Recombinant Protein Drugs Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2015 Sanofi Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Sanofi Recombinant Protein Drugs Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Eli Lilly Recombinant Protein Drugs Business Region Distribution
Table Merck Serono Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Serono Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Merck Serono Recombinant Protein Drugs Business Region Distribution
Table Ortho Biotech Information List
Table Product A Overview
Table Product B Overview
Table 2016 Ortho Biotech Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Ortho Biotech Recombinant Protein Drugs Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Roche Recombinant Protein Drugs Business Region Distribution
Table Kyowa Hakko Kirin Information List
Table Product A Overview
Table Product B Overview
Table 2016 Kyowa Hakko Kirin Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Kyowa Hakko Kirin Recombinant Protein Drugs Business Region Distribution
Table Pharmingen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pharmingen Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Pharmingen Recombinant Protein Drugs Business Region Distribution
Table Abcam Information List
Table Product A Overview
Table Product B Overview
Table 2016 Abcam Recombinant Protein Drugs Revenue (Million USD), Sales (K Doses), Ex-factory Price (USD/Dose)
Figure 2016 Abcam Recombinant Protein Drugs Business Region Distribution
Table GenSci Information List
Table SL PHARM Information List
Table Dongbao Pharm Information List
Table Ankebio Information List
Table NCPC Information List
Table Heng Rui Information List
Figure Global 2017-2022 Recombinant Protein Drugs Market Size (K Doses) and Growth Rate Forecast
Figure Global 2017-2022 Recombinant Protein Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Recombinant Protein Drugs Sales Price (USD/Dose) Forecast
Figure North America 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Figure China 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Figure Europe 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Figure Japan 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Figure India 2017-2022 Recombinant Protein Drugs Consumption Volume (K Doses) and Growth Rate Forecast
Table Global Sales Volume (K Doses) of Recombinant Protein Drugs by Type 2017-2022
Table Global Consumption Volume (K Doses) of Recombinant Protein Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Recombinant Protein Drugs by Region